retatrutide and test E 300-350, - 3mg Weekly (1mg, Mon, Wed, Fr), Retatrutide 40mg Research Peptide Pen

Published Phase 2 and Phase 3 trials for both molecules enrol as monotherapy (with or without background T2D therapy such as metformin or insulin)

When possible, change one variable at a time

The Role of Reliable Analytical Testing While retatrutide represents a significant advancement in peptide research, it also introduces analytical challenges that must be carefully managed

When a small group of patients began taking a very tiny dose starting at 0.0675 mg, compared to the label-recommended 0.25 mg and increased it gradually, they were able to tolerate it better than the folks who started the usual dose and tried to escalate it in the typical way, says Alkhaddo

D., DiMarchi, R

Self-administering or sourcing unlicensed medications online carries serious health risks, including unknown product purity, incorrect dosing, and dangerous drug interactions